Presentation TCT 2025 Cerebral Embolic Protection Devices for Stroke Prevention: Is there Still a Role? Presenter: Grant William Reed October 28, 2025
Presentation TCT 2025 TCT 317: Impact of Very Severe Aortic Stenosis on Periprocedural Stroke Risk After Transcatheter Aortic Valve Replacement Presenter: Jung-Joon Cha October 26, 2025
Presentation TCT 2025 TCT 319: Short -Term Clinical Effect of Cerebral Embolic Protection Device Following Transcatheter Aortic-Valve Replacement in Korea Population: The Sentinel Registry (Sentinel) Presenter: Han Su Park October 26, 2025
Presentation TCT 2025 TCT 318: Stroke after TAVR - Impact on Clinical Outcome and Patient Reported Quality of Life (QoL): The Michigan Structural Heart Consortium (MISHC) Experience Presenter: P. Michael Grossman October 26, 2025
Presentation TCT 2025 TCT 322: Routine Use of Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials Presenter: Hasan Ilyas October 26, 2025
Presentation TCT 2025 TCT 321: Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials Presenter: Mostafa Ali October 26, 2025
Presentation TCT 2025 TCT 21: Utility of Cerebral Embolic Protection in Transcaval Transcatheter Aortic Valve Replacement Presenter: Victoria Coombe October 25, 2025
Presentation TCT 2025 TCT 227: Routine Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials Presenter: Mahmoud Ismayl October 25, 2025